Literature DB >> 18070817

Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination.

Pasquale Florio1, Luca Bruni, Carmen De Falco, Gilda Filardi, Michela Torricelli, Fernando M Reis, Letizia Galleri, Chiara Voltolini, Caterina Bocchi, Vincenzo De Leo, Felice Petraglia.   

Abstract

BACKGROUND: Urocortin is a neuropeptide produced by the human endometrium and has biological effects putatively important for promoting blastocyst implantation. We measured urocortin concentrations in samples of endometrial wash fluid collected from women with unexplained infertility who underwent intrauterine insemination (IUI).
METHODS: Patients 28-42 years of age (n = 71) were consecutively enrolled after a complete clinical evaluation. Endometrial wash fluid was retrieved before IUI, at the time of ultrasound evaluation of endometrial thickness. Urocortin concentrations were assayed with a specific ELISA.
RESULTS: After IUI, 28 patients (39%) became pregnant. Urocortin concentrations were significantly higher in women who became pregnant than in those who did not (0.38 microg/L vs 0.13 microg/L, P <0.0001). At a cutoff of 0.321 microg/L, urocortin results were positive in 61% [95% confidence interval (CI), 41%-78%] of women who had successful implantation and negative in 98% (95% CI, 88%-99.6%) of those who did not. The pregnancy rate for women with urocortin concentrations >0.32 microg/L was 94%, which differed significantly (P <0.05) from the overall pregnancy rate of 39% in the study population.
CONCLUSIONS: Urocortin is measurable in endometrial wash fluid, and its concentrations before IUI are higher in women who subsequently achieve pregnancy. These data suggest that the probability of having a successful pregnancy-producing IUI may be better estimated by measuring urocortin in endometrial wash fluid.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070817     DOI: 10.1373/clinchem.2007.094987

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy.

Authors:  L E Borges; A W Horne; S E McDonald; J L V Shaw; P C Lourenco; F Petraglia; H O D Critchley
Journal:  Reprod Sci       Date:  2010-10-26       Impact factor: 3.060

2.  Letrozole Versus Clomiphene Citrate and Natural Cycle: Endometrial Receptivity During Implantation Window in Women With Polycystic Ovary Syndrome.

Authors:  Li Wang; Shulan Lv; Fen Li; E Bai; Xiaofeng Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-18       Impact factor: 5.555

Review 3.  Corticotropin-Releasing Factor Family: A Stress Hormone-Receptor System's Emerging Role in Mediating Sex-Specific Signaling.

Authors:  Lahari Vuppaladhadiam; Cameron Ehsan; Meghana Akkati; Aditi Bhargava
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.